Covered recipient · General Payments record
ZOHAIB IJAZ
Allopathic & Osteopathic Physicians Internal Medicine Gastroenterology
General Payments · PY2025
$294.12
- Reported across 14 records
- CMS publication 2026-06-30
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2025 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $294.12 | 14 |
By paying entity
PY2025 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| PFIZER INC. | $78.43 | 4 |
| Takeda Pharmaceuticals U.S.A., Inc. | $71.23 | 3 |
| ABBVIE INC. | $51.87 | 3 |
| ERBE USA INC | $40.00 | 1 |
| Janssen Biotech, Inc. | $18.52 | 1 |
| AIMMUNE THERAPEUTICS, INC. | $18.41 | 1 |
| Azurity Pharmaceuticals, Inc. | $15.66 | 1 |
By program year
All program years on this page · sorted by year
| Program year | Amount | Records |
|---|---|---|
| PY2025 | $294.12 | 14 |
Payment records · PY2025 (14)
Ordering applied by this site (paying entity, then date) · record values are shown as CMS published them
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $16.78 | 07/24/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1202091706 | CMS |
| ABBVIE INC. | $13.48 | 09/11/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1202091708 | CMS |
| ABBVIE INC. | $21.61 | 10/20/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1202091710 | CMS |
| Aimmune Therapeutics, Inc. | $18.41 | 12/16/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1249649719 | CMS |
| Azurity Pharmaceuticals, Inc. | $15.66 | 12/15/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1242672772 | CMS |
| ERBE USA Inc | $40.00 | 07/30/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1233181535 | CMS |
| Janssen Biotech, Inc. | $18.52 | 10/28/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1174372790 | CMS |
| PFIZER INC. | $18.61 | 07/23/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1229033271 | CMS |
| PFIZER INC. | $22.77 | 08/13/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1229112675 | CMS |
| PFIZER INC. | $18.44 | 10/15/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1229521337 | CMS |
| PFIZER INC. | $18.61 | 12/03/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1229601753 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $27.37 | 09/18/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1223909793 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $23.81 | 10/16/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1223887895 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $20.05 | 11/12/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1223857767 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2025
- Source files
- Dataset page · Bulk file · PY2025
- Generated from
- OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.